COVID-19 Pop Quiz: 5 Questions on the Latest News from Patient Care

March 18, 2020
Sydney Jennings
Sydney Jennings

Refresh your memory of the week's top headlines on the COVID-19 pandemic with our 5-question pop quiz.

Whether it be newly reported cases or travel bans being put into place, coronavirus disease 2019 (COVID-19) has taken over the airwaves across the globe. New information is being published at a rapid rate and while it is always better to be informed, the constant influx of COVID-19 news can be overwhelming-especially for physicians with limited time. To help refresh your memory, we compiled a quick, 5-question pop quiz on the leading COVID-19 headlines from Patient Care® Online from the past week. See how much you remember below. 

1. The first patient to receive the investigational vaccine mRNA-1430, developed to protect against COVID-19, was administered the subcutaneous injection on Monday, March 16, 2020.

A. True
B. False

Please click below for answer, discussion, and next question.

Answer: B. False. The first patient to receive the investigational vaccine developed to protect against COVID-19 was on Monday, March 16, 2020. The vaccine, however, is currently called mRNA-1273, not mRNA-1430. 

 

2. Cardiovascular disease (CVD) patients diagnosed with COVID-19 should be fully evaluated before adding or removing treatment with angiotensin receptor blockers (ARBs) or angiotensin converting enzyme inhibitors (ACE-i).

A. True
B. False

Please click below for answer, discussion, and next question.

Answer: A. True. The American Heart Association, the Heart Failure Society of America, and the American College of Cardiology released a joint statement on March 17, 2020 recommending patients with CVD who are diagnosed with COVID-19 should be evaluated before adding or removing ACE-i or ARB treatment. Any changes to their treatment should be based on the latest scientific evidence and shared decision making with their physician.

 

3. New research from Columbia University found that per person, undocumented cases of COVID-19 in China were half as contagious as documented cases, but were the source of approximately what percentage of documented cases?

A. 20%
B. 35%
C. 50%
D. 63%
E. 79%

Please click below for answer, discussion, and next question.

Answer: E. 79%. Using a computer model based on observations of reported COVID-19 infection and spread within China along with mobility data prior to the January 23 country-wide travel ban, researchers found that 86% of all COVID-19 infections in China were undocumented before the travel shutdown. Per person, the undocumented cases were half (55%) as contagious as documented cases but accounted for 79% of documented infections. 

 

4. The American Diabetes Association (ADA) recommends physicians educate their diabetes patients on emergency warning signs of COVID-19 infection which include all of the following except:

A. Difficulty breathing or shortness of breath
B. Bluish lips or face
C. Syncope
D. Persistent pain or pressure in the chest
E. New confusion or inability to arouse

Please click below for answer, discussion, and next question.

Answer: C. Syncope. The ADA released their list of suggestions for patients with diabetes to protect themselves against COVID-19 and they recommended physicians educate their diabetes patients on emergency warning signs of COVID-19 which include difficulty breathing or shortness of breath, bluish lips or face, persistent pain or pressure in the chest, and new confusion or inability to arouse.

 

5. Rx.Health is putting together a digital toolkit for hospitals that will make screening and virtual care easier for COVID-19. Rx.Health is a spinoff of which major US health system:

A. Johns Hopkins Health System
B. Mount Sinai Health System
C. Kaiser Permanente
D. UCLA Health

Please click below for answer and discussion.

Answer: B. Mount Sinai Health System, in New York. The Mount Sinai Health System spinoff Rx.Health announced this week a digital toolkit they are creating that will make it easier for hospitals to implement screening and virtual care for COVID-19.

Visit our COVID-19 Resource Page for more information.